Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Critical reviews in clinical laboratory sciences

• Publication date

  2015-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10408363.2014.972497PMID 25397345
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of an accelerated high‐sensitivity troponin T assay protocol in an Australian cohort with chest pain

  2014cited by this paper
• Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome.

  2014cited by this paper
• Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction.

  2014cited by this paper
• Autoantibody prevalence with an improved immunoassay for detecting cardiac troponin-specific autoantibodies

  2014cited by this paper
• Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls.

  2014cited by this paper
• Circulating cardiac troponin T exhibits a diurnal rhythm.

  2014cited by this paper
• Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.

  2014cited by this paper
• Use of observed within-person variation of cardiac troponin in emergency department patients for determination of biological variation and percentage and absolute reference change values.

  2014cited by this paper
• Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary.

  2014cited by this paper
• What is the 30-day rate of adverse cardiac events in chest pain patients with ED troponin I assays⩽99th centile using a contemporary sensitive assay? An exploratory analysis

  2014cited by this paper
• Effect of recalibration of the hs-TnT assay on diagnostic performance

  2014cited by this paper
• Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial.

  2014cited by this paper
• Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction.

  2014cited by this paper
• The global need to define normality: the 99th percentile value of cardiac troponin.

  2014cited by this paper
• Is it time to do away with the 99th percentile for cardiac troponin in the diagnosis of acute coronary syndrome and the assessment of cardiac risk?

  2014cited by this paper
• Development and validation of the Emergency Department Assessment of Chest pain Score and 2 h accelerated diagnostic protocol

  2014cited by this paper
• Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population.

  2013cited by this paper
• Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender.

  2013cited by this paper
• Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population

  2013cited by this paper
• Interference from heterophilic antibodies in troponin testing. Case report and systematic review of the literature.

  2013cited by this paper
• Classification of myocardial infarction: frequency and features of type 2 myocardial infarction.

  2013cited by this paper
• The third universal definition of myocardial infarction

  2013cited by this paper
• Implications of adjustment of high-sensitivity cardiac troponin T assay.

  2013cited by this paper
• Defining a reference population to determine the 99th percentile of a contemporary sensitive cardiac troponin I assay.

  2013cited by this paper
• Factors influencing the 99th percentile of cardiac troponin I evaluated in community-dwelling individuals at 70 and 75 years of age.

  2013cited by this paper
• Implications of adjustment of high-sensitivity cardiac troponin T assay.

  2013cited by this paper
• Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease.

  2013cited by this paper
• Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin.

  2013cited by this paper
• Delta troponin for the early diagnosis of AMI in emergency patients with chest pain.

  2013cited by this paper
• Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population.

  2013cited by this paper
• Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome.

  2013cited by this paper
• Defining high-sensitivity cardiac troponin concentrations in the community.

  2013cited by this paper
• Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays.

  2013cited by this paper
• What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department?: a clinical survey.

  2013cited by this paper
• Prevalence, extent, and independent predictors of silent myocardial infarction.

  2013cited by this paper
• The distribution of cardiac troponin I in a population of healthy children: lessons for adults.

  2013cited by this paper
• Unstable Angina: Is It Time for a Requiem?

  2013cited by this paper
• Long-term biological variation in cardiac troponin I.

  2012cited by this paper
• Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay.

  2012cited by this paper
• Longitudinal studies of cardiac troponin I in a large cohort of healthy children.

  2012cited by this paper
• Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome.

  2012cited by this paper
• Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department.

  2012cited by this paper
• A comprehensive review of upper reference limits reported for (high-)sensitivity cardiac troponin assays: the challenges that lie ahead

  2012cited by this paper
• Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study.

  2012cited by this paper
• Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population

  2012cited by this paper
• Influence of population selection on the 99th percentile reference value for cardiac troponin assays.

  2012cited by this paper
• Third universal definition of myocardial infarction.

  2012cited by this paper
• Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population.

  2012cited by this paper
• Variation of cardiac troponin I and T measured with sensitive assays in emergency department patients with noncardiac chest pain.

  2012cited by this paper
• One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T.

  2012cited by this paper
• 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial.

  2012cited by this paper
• Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods.

  2011cited by this paper
• Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T.

  2011cited by this paper
• False positive troponin result caused by a true macrotroponin

  2011cited by this paper
• Biologic variation of a novel cardiac troponin I assay.

  2011cited by this paper
• World Health Organization definition of myocardial infarction: 2008-09 revision.

  2011cited by this paper
• Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome.

  2011cited by this paper
• High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population.

  2011cited by this paper
• Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction

  2011cited by this paper
• High-sensitivity troponin T for early rule-out of myocardial infarction in recent onset chest pain

  2011cited by this paper
• Multicenter analytical evaluation of a high-sensitivity troponin T assay.

  2011cited by this paper
• Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay.

  2011cited by this paper
• Analytical validation of a high-sensitivity cardiac troponin T assay.

  2010cited by this paper
• Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy

  2010cited by this paper
• What criteria should be used to assess troponin assays?

  2010cited by this paper
• Standardisation of cardiac troponin I measurement: past and present

  2010cited by this paper
• Autoantibodies to cardiac troponin in acute coronary syndromes.

  2010cited by this paper
• Sensitive troponin I assay in early diagnosis of acute myocardial infarction

  2010cited by this paper
• Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay.

  2010cited by this paper
• Women with acute coronary syndrome are less invasively examined and subsequently less treated than men.

  2010cited by this paper
• The etiology and prognostic significance of cardiac troponin I elevation in unselected emergency department patients.

  2010cited by this paper
• Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.

  2010cited by this paper
• Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay.

  2010cited by this paper
• Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction.

  2010cited by this paper
• The impact of the 2007 ESC-ACC-AHA-WHF Universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study.

  2010cited by this paper
• Sensitive troponin I assay in early diagnosis of acute myocardial infarction.

  2009cited by this paper
• Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice.

  2009cited by this paper
• Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays.

  2009cited by this paper
• Contemporary Reviews in Interventional Cardiology Coronary Intervention in 2009 Are Women No Different Than Men ?

  2009cited by this paper
• Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making.

  2009cited by this paper
• Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure.

  2009influential reference
• A new season for cardiac troponin assays: it's time to keep a scorecard.

  2009cited by this paper
• Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events.

  2009cited by this paper
• What Criteria Should Be Used to Assess Troponin Assays?

  2009cited by this paper
• Precision performance at low levels and 99th percentile concentration of the Access® AccuTnI® assay on two different platforms

  2009cited by this paper
• Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury.

  2009cited by this paper
• Frequency of elevated troponin I and diagnosis of acute myocardial infarction.

  2009cited by this paper
• Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.

  2009cited by this paper
• Interpreting troponin elevations: do we need multiple diagnoses?

  2008cited by this paper
• Troponin revisited 2008: assay performance

  2008cited by this paper
• Chest pain in the emergency room: value of the HEART score

  2008cited by this paper
• Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

  2008cited by this paper
• Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd-generation assays.

  2007cited by this paper
• Improved identification of acute coronary syndromes with delta cardiac serum marker measurements during the emergency department evaluation of chest pain patients

  2007cited by this paper
• Reporting of cardiac troponin - problems with the 99th population percentile.

  2007cited by this paper
• The Internet Tracking Registry of Acute Coronary Syndromes (i*trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies.

  2006cited by this paper
• Performance evaluation and subsequent clinical experience with the Abbott Automated Architect STAT Troponin-I assay.

  2006cited by this paper
• Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide.

  2006cited by this paper
• A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry

  2004cited by this paper
• British Cardiac Society Working Group on the definition of myocardial infarction

  2004cited by this paper

• Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance

  2023cites this paper
• Does a Code for Acute Myocardial Infarction Mean the Same in All Norwegian Hospitals? A Likelihood Approach to a Medical Record Review

  2022cites this paper
• The effect of the immunoassay curve fitting routine on bias in troponin

  2022cites this paper
• Integrating Quality Control and External Quality Assurance.

  2021cites this paper
• Polymer-free sirolimus-eluting stent use in Europe and Asia: Ethnic differences in demographics and clinical outcomes

  2020cites this paper
• Elevace vysoce senzitivního troponinu u stavů mimo akutní koronární syndrom - výzva pro lékaře urgentního příjmu

  2020cites this paper
• Non-acute coronary syndrome elevations of high-sensitivity troponin - a challenge for the emergency physician

  2020cites this paper
• Characterising a novel biomarker of early myocardial injury

  2019influential citation
• Establishing consensus-based, assay-specific 99th percentile upper reference limits to facilitate proper utilization of cardiac troponin measurements

  2017cites this paper
• Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome

  2017cites this paper
• Cross-sectional study of high-sensitivity cardiac troponins T and I in a hospital and community outpatient setting.

  2017cites this paper
• Quantifying the Release of Biomarkers of Myocardial Necrosis from Cardiac Myocytes and Intact Myocardium.

  2017cites this paper
• The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications

  2017cites this paper
• Statistical issues with the determination of the troponin 99th percentile - Not just a problem for troponin?

  2016cites this paper
• Accelerated strategies in the assessment of emergency patients with possible acute coronary syndromes

  2015cites this paper
• Recommendation of the Czech Society of Clinical Biochemistry: the use of cardiac troponins in suspected acute coronary syndrome

  2015cites this paper